Assessing the Alignment of Biomedical Research and Clinical Translation
Sun, M.; Stoeger, T.; Amaral, L. A. N.
Show abstract
More than half of later stage drug clinical trials fail due to lack of efficacy, highlighting gaps in our understanding of disease-target relationships. While it is widely believed that scientific research is essential for identifying drug-targets, whether scientists can allocate their research attention according to the clinical potential of disease-target relationships is remains a matter of debate. To address this knowledge gap, we analyzed data from Open Targets, a comprehensive disease-target relationship platform. We build an automated open pipeline that follows drugs through consecutive clinical trial phases and use it to uncover that research attention in the disease-specific primary literature has some predictive power for trial success. However, research attention toward specific targets are not predictive for overall trial success across diseases. Our study thus highlights the crucial, yet complex, role of the primary research literature in steering clinical trials, encouraging a more nuanced approach to translational medicine.
Matching journals
The top 10 journals account for 50% of the predicted probability mass.
Similar papers in this journal
Similar papers in this journal
Similar papers in this journal
"Similar papers" are the closest papers from that journal in the model's embedding space. They show what the match is built on, but the ranking comes mostly from a classifier over the whole training set, not from these examples alone.